Clinical Oncology: ASCO, COA to Congress: Part B Drug Model Is Bad Medicine

Representatives of the American Society of Clinical Oncology (ASCO) and the Community Oncology Alliance (COA) urged Congress to stop a Medicare Part B demonstration project, which they say will have ...

Modern Healthcare: Senators echo call for investigation over Medicaid rebates for EpiPen

Republicans on the Senate Finance Committee have joined the chorus calling for an investigation into Medicaid’s handling of manufacturer rebates for EpiPen. The 14 Republicans on the committee sent a ...

NiagaraHub: Crucial Drug Discount Program at Risk [by Joseph A. Ruffolo]

Niagara Falls Memorial Medical Center is a safety-net facility. That means we treat all sick people regardless of their ability to pay. Many of our patients are on Medicaid, Medicare ...

DOTmed: Health care and the law: winds of change buffet community oncology

The combination of the BBA site neutrality provisions and the proposed changes in the 340B program is likely to chill or kill some projects that have been on hospital drawing ...

Austin American-Statesman: Commentary: Continue drug pricing program for families in need

Last year, as my little girl was transitioning to adulthood, she experienced headaches so painful that we raced to the hospital fearing meningitis. The doctors at Dell Children’s quickly ruled ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields